Estimaciones de analistas de Wall Street para Kymera Therapeutics, Inc. (KYMR): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-03 | $-1.25 | ||
| 2026-08-05 | $-0.62 | $-0.71 | +13.0% |
| 2026-04-30 | $-0.71 | $-0.89 | +20.2% |
| 2026-02-26 | $-0.97 | $-0.78 | -23.8% |
| 2025-11-04 | $-0.90 | $-0.71 | -26.8% |
| 2025-08-11 | $-0.95 | $-0.83 | -14.5% |
| 2025-05-09 | $-0.82 | $-0.92 | +10.9% |
| 2025-02-27 | $-0.88 | $-0.76 | -15.8% |
Ratios de valoración
| Precio / Valor contable | 7.56 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | $2.9M | $34.0M | $72.8M | $46.8M | $78.6M | $47.1M | $39.2M |
| Coste de Ventas | $205000 | $825000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$205000 | $2.1M | $34.0M | $72.8M | $46.8M | $78.6M | $47.1M | $39.2M |
| I+D | $17.7M | $37.2M | $62.1M | $137.0M | $164.2M | $189.1M | $240.2M | $316.6M |
| Generales y Administrativos | $3.8M | $8.0M | $18.2M | $36.3M | $43.8M | $55.0M | $63.5M | $68.2M |
| Gastos Operativos | $21.5M | $45.1M | $80.3M | $173.4M | $208.1M | $244.1M | $308.7M | $388.6M |
| Beneficio Operativo | -$21.5M | -$42.2M | -$46.3M | -$100.5M | -$161.3M | -$165.5M | -$261.6M | -$349.4M |
| EBITDA | -$21.2M | -$40.4M | -$43.7M | -$97.6M | -$151.7M | -$143.2M | -$216.2M | -$303.1M |
| Gastos por Intereses | $16000 | $46000 | $115000 | $175000 | $176000 | $196000 | $249000 | $249000 |
| Beneficio Antes de Impuestos | -$21.5M | -$41.2M | -$45.6M | -$100.2M | -$154.8M | -$147.0M | -$223.9M | -$311.6M |
| Impuestos | $43859 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$21.5M | -$41.3M | -$45.6M | -$100.2M | -$154.8M | -$147.0M | -$223.9M | -$311.4M |
| BPA | $-0.48 | $-0.93 | $-0.99 | $-2.09 | $-2.87 | $-2.52 | $-2.98 | $-3.69 |
| BPA Diluido | $-0.48 | $-0.93 | $-0.99 | $-2.09 | $-2.87 | $-2.52 | $-2.98 | $-3.69 |
| Acciones en Circulación (Diluidas) | $44.5M | $44.5M | $44.6M | $48.0M | $53.9M | $58.4M | $75.0M | $84.4M |
Precio
| Precio | $116.33 |
| Capitalización | $9.6B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: AAPG · ACAD · ACLX · AKRO · CRNX · IMVT · NAMS
Explorar sector: Healthcare · Biotechnology
Más secciones de KYMR: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones